论文部分内容阅读
目的：通过对乳癌综合治疗的回顾性总结，探讨提高乳癌生存率的最佳综合治疗方案。材料与方法：收治经病理证实准备实行术后放疗、化疗的乳腺癌的患者８１４例，按ＵＩＣＣ的ＴＮＭ分期法，有Ⅲ期患者３１３例，占３８．５％，分别归入规范化综合治疗组和非规范化综合治疗组，均随访５年以上。结果：乳癌患者的５年生存率、１０年生存率，在规范化治疗组分别为５１４１％、４２．６２％，非规范化治疗组分别为３６．８４％、２８．７７％，经统计学处理，两组之间的５年生存率和１０年生存率均有显著差异。
OBJECTIVE: To review the comprehensive review of breast cancer comprehensive treatment and explore the best comprehensive treatment plan to improve the survival rate of breast cancer. Materials and Methods: A total of 814 patients with pathologically confirmed breast cancer undergoing postoperative radiotherapy and chemotherapy were included. According to the UICC TNM staging method, there were 313 patients with stage III, accounting for 38.5%, and were included in the standardized comprehensive treatment group. Non-standardized comprehensive treatment groups were followed up for more than 5 years. Results: The 5-year survival rate and 10-year survival rate of breast cancer patients were 51.41% and 42.62% in the standardized treatment group and 36.84% and 28.77% in the non-standardized treatment group, respectively. For treatment, there was a significant difference between the two groups in 5-year survival rate and 10-year survival rate.